How does NAD+ supplementation affect mitochondrial health in aging muscles?

Nicotinamide adenine dinucleotide ($\text{NAD}^+$) plays a critical role in muscle development, homeostasis, and aging by supporting energy metabolism, mitochondrial function, and SIRT1 activity. In aging muscles, $\text{NAD}^+$ levels decline, but precursors like nicotinamide mononucleotide ($\text{NMN}$) have shown promise in preclinical and early human studies for supporting metabolic health.

Small human clinical trials, such as randomized, placebo-controlled, double-blind investigations, have tested precursors like $\text{NMN}$ to evaluate effects on body composition and insulin sensitivity in prediabetic women^[1]. Animal and laboratory evidence indicates that $\text{NMN}$ can suppress age-associated weight gain, enhance physical activity and energy metabolism, improve insulin sensitivity, and restore skeletal muscle in aged mice^[2].

Regarding dosing and supplement considerations, different precursors have distinct biochemical profiles. For instance, while nicotinamide ($\text{NAM}$) can preserve $\text{NAD}^+$ under stress, combining exercise training with $\text{NAM}$ supplementation has been observed to decrease SIRT1 levels because $\text{NAM}$ can inhibit SIRT1 and PARP-1 activity^[3]. Consequently, $\text{NAM}$ may be less effective than other methods for enhancing $\text{NAD}^+$ and SIRT1 activity in aging muscle^[4], highlighting that precursor choice and optimal dosing strategies remain important variables in clinical research.

Understanding how specific precursors interact with cellular pathways helps clarify these metabolic effects: